Firas Zahr
Latest contributions
CLASP IID one-year outcomes - Transcatheter edge-to-edge repair systems for degenerative MR
27 Oct 2023
Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.
The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...
Author
Author
Author
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Intrepid early experience
23 Nov 2021 – From PCR London Valves 2021
This session of PCR London Valves 2021 needs to be watched to learn more about Medtronic's mitral and tricuspid clinical trial updates, better understand treatable anatomies for TMVR, and gain awareness on early feasibility Intrepid data.
Advances in investigational mitral and tricuspid therapies
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard, Vinayak Bapat, Thomas Modine, Firas Zahr and Azeem Latib in order to see a review of the Medtronic TMVR/TTVR EFS studies and system, to review one mitral EFS case and one tricuspid EFS case, and to discuss future of TMVR/TTVR in...
